Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	12017050	12017050	C	G	exonic	PLOD1	.	nonsynonymous SNV	PLOD1:NM_000302:exon7:c.C720G:p.I240M,PLOD1:NM_001316320:exon8:c.C861G:p.I287M	2.70E-07	0.995480792	0.004518938	DISEASE: Ehlers-Danlos syndrome 6 (EDS6) [MIM:225400]: A connective tissue disorder characterized by generalized joint hypermobility, hyperextensible skin, atrophic cutaneous scars due to tissue fragility, progressive kyphoscoliosis already present at birth, ocular manifestations, arterial rupture, easy bruising, severe neonatal muscle hypotonia and delayed motor development. {ECO:0000269|PubMed:10686424, ECO:0000269|PubMed:15666309, ECO:0000269|PubMed:15854030, ECO:0000269|PubMed:15979919, ECO:0000269|PubMed:8163671, ECO:0000269|PubMed:9617436}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25274	.	-0.657684922	16.09459778	3458.35803	11.29956	0.001	0.784	D	0.846	0.448	P	0.577	0.507	P	0.000	0.629	D	1.000	0.513	D	2.715	0.797	M	-0.38	0.690	T	-2.51	0.545	D	0.613	0.678	-0.556	0.666	T	0.330	0.698	T	0.066	0.699	D	2.763	0.393	21.2	0.995	0.704	0.609	0.311	D	c	-0.135	-0.258	0.658	0.222	0.707	0.730	0	-0.488	0.114	-0.313	0.081	0.024	0.147	0.286	0.250	0.971	0.463	4.767	0.124	.	.	.	0.5	90	172	chr1	12017050	chr1:12017050	C	G	90	PASS	AN=2;DP=172	GT	0/1
chr1	16975411	16975411	G	C	ncRNA_exonic	MST1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	141	chr1	16975411	chr1:16975411	G	C	107	PASS	AN=2;DP=141	GT	0/1
chr1	16975787	16975787	C	T	ncRNA_intronic	MST1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	200	chr1	16975787	chr1:16975787	C	T	.	PASS	AN=0;DP=200	GT	0/1
chr1	23966894	23966894	-	AAG	exonic	MDS2	.	nonframeshift insertion	MDS2:NM_001348075:exon7:c.278_279insAAG:p.R95_K96insR	0.042965573	0.662011892	0.295022535	.	0.06917	.	.	.	3048.37206	10.49529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	24	chr1	23966894	chr1:23966894	T	TAAG	82	PASS	AN=2;DP=24	GT	0/1
chr1	25747230	25747230	G	C	exonic	RHCE	.	nonsynonymous SNV	RHCE:NM_001330430:exon1:c.C48G:p.C16W,RHCE:NM_020485:exon1:c.C48G:p.C16W,RHCE:NM_138616:exon1:c.C48G:p.C16W,RHCE:NM_138617:exon1:c.C48G:p.C16W,RHCE:NM_138618:exon1:c.C48G:p.C16W	0.861454126	0.138457773	8.81E-05	.	0.18894	0.11913	1.686630123	96.38476056	2200.98585	8.63676	1.0	0.067	T	0.001	0.067	B	0.006	0.112	B	0.624	0.107	N	1	0.090	P	.	.	.	2.26	0.235	T	2.64	0.002	N	0.101	0.429	-0.901	0.479	T	0.000	0.000	T	.	.	.	-1.010	0.032	0.015	0.633	0.070	0.014	0.047	N	c	-1.190	-1.252	1.000	0.441	0.554	0.283	0	0.628	0.168	-0.607	0.057	-0.492	0.052	0.000	0.063	0.157	0.207	3.072	0.058	.	ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000259984.1|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14|ENSG00000183726.6|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000204178.5|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14|ENSG00000204178.5|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000187010.14|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000187010.14|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000187010.14|ENSG00000261349.1|ENSG00000188672.12|ENSG00000224183.1|ENSG00000183726.6|ENSG00000187010.14|ENSG00000117616.13|ENSG00000188672.12|ENSG00000259984.1|ENSG00000261349.1|ENSG00000187010.14|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000204178.5|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000187010.14|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000224183.1|ENSG00000183726.6|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000261349.1|ENSG00000187010.14|ENSG00000204178.5|ENSG00000188672.12|ENSG00000261349.1|ENSG00000224183.1|ENSG00000183726.6|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000183726.6|ENSG00000187010.14|ENSG00000259984.1|ENSG00000261349.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adrenal_Gland|Adrenal_Gland|Adrenal_Gland|Adrenal_Gland|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Coronary|Artery_Coronary|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Brain_Caudate_basal_ganglia|Brain_Caudate_basal_ganglia|Brain_Cerebellar_Hemisphere|Brain_Cerebellar_Hemisphere|Brain_Cerebellar_Hemisphere|Brain_Cerebellum|Brain_Cortex|Brain_Cortex|Brain_Frontal_Cortex_BA9|Brain_Frontal_Cortex_BA9|Brain_Frontal_Cortex_BA9|Brain_Hippocampus|Brain_Nucleus_accumbens_basal_ganglia|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Cells_EBV-transformed_lymphocytes|Cells_EBV-transformed_lymphocytes|Cells_EBV-transformed_lymphocytes|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Heart_Left_Ventricle|Heart_Left_Ventricle|Liver|Lung|Lung|Lung|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Pancreas|Pancreas|Pituitary|Pituitary|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Stomach|Stomach|Testis|Testis|Testis|Testis|Thyroid|Thyroid|Thyroid|Thyroid|Thyroid|Vagina|Whole_Blood|Whole_Blood|Whole_Blood|Whole_Blood|Whole_Blood	0.5	101	149	chr1	25747230	chr1:25747230	G	C	101	PASS	AN=2;DP=149	GT	0/1
chr1	93704794	93704794	T	-	intronic	CCDC18	.	.	.	.	.	.	.	0.10485	0.09565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	22	chr1	93704793	chr1:93704793	CT	C	67	PASS	AN=2;DP=22	GT	0/1
chr1	143195951	143195951	G	T	ncRNA_intronic	LOC102723769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	chr1	143195951	chr1:143195951	G	T	.	PASS	AN=0;DP=85	GT	0/1
chr1	148890217	148890217	G	A	ncRNA_exonic	LOC101927429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	131	chr1	148890217	chr1:148890217	G	A	87	PASS	AN=2;DP=131	GT	0/1
chr1	153897055	153897055	T	-	intergenic	GATAD2B;DENND4B	dist=1604;dist=4922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	459	chr1	153897054	chr1:153897054	AT	A,ATT	60	PASS	AN=2;DP=459	GT	0/1
chr1	153897055	153897055	-	T	intergenic	GATAD2B;DENND4B	dist=1604;dist=4922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	459	chr1	153897054	chr1:153897054	AT	A,ATT	60	PASS	AN=2;DP=459	GT	0/1
chr1	155106615	155106615	G	A	UTR3	EFNA1	NM_004428:c.*72G>A;NM_182685:c.*72G>A	.	.	0.872063428	0.126248046	0.001688526	.	0.11427	0.20761	0.25917371	70.05779665	2215.21898	8.66769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	102	chr1	155106615	chr1:155106615	G	A	75	PASS	AN=2;DP=102	GT	0/1
chr1	180404391	180404391	-	T	intronic	ACBD6	.	.	.	0.064959259	0.920160983	0.014879758	.	0.46704	0.10684	-0.427900189	25.14744043	16.07879	0.56883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	288	chr1	180404391	chr1:180404391	A	AT	92	PASS	AN=2;DP=288	GT	0/1
chr1	248112554	248112554	T	C	exonic	OR2L8	.	nonsynonymous SNV	OR2L8:NM_001001963:exon1:c.T395C:p.L132P	0.17916862	0.766561924	0.054269456	.	0.05102	0.09448	2.396009417	98.49020996	223.42356	3.23122	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.405	0.131	N	1	0.090	N	-1.51	0.005	N	5.99	0.006	T	7.42	0.000	N	0.136	0.157	-0.991	0.324	T	0.001	0.002	T	0.000	0.001	T	-2.726	0.002	0.001	0.371	0.024	0.001	0.007	N	c	-2.527	-2.516	0.001	0.076	0.487	0.133	0	-3.28	0.047	-7.320	0.000	-5.127	0.000	0.000	0.063	0.000	0.016	2.974	0.055	GPCR, rhodopsin-like, 7TM	.	.	0.5	100	71	chr1	248112554	chr1:248112554	T	C	100	PASS	AN=2;DP=71	GT	0/1
chr2	109404474	109404474	-	T	intronic	CCDC138	.	.	.	1.08E-05	0.986815955	0.013173211	.	0.15822	.	-0.464712395	23.5727766	2253.24012	8.76685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	49	chr2	109404474	chr2:109404474	C	CT	65	PASS	AN=2;DP=49	GT	0/1
chr2	132121350	132121350	G	C	UTR5	WTH3DI	NM_001077637:c.-57C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	168	chr2	132121350	chr2:132121350	G	C	124	PASS	AN=2;DP=168	GT	0/1
chr2	187713713	187713713	G	T	exonic	ZSWIM2	.	nonsynonymous SNV	ZSWIM2:NM_182521:exon1:c.C145A:p.P49T	5.14E-10	0.363952929	0.63604707	.	0.12176	0.09356	2.311417714	98.35456476	1579.85177	7.35626	0.137	0.259	T	0.01	0.144	B	0.005	0.104	B	0.042	0.239	N	0.925	0.272	N	2.175	0.612	M	1.89	0.237	T	-0.73	0.206	N	0.439	0.494	-1.047	0.151	T	0.041	0.177	T	0.013	0.317	T	3.032	0.425	22.3	0.962	0.284	0.615	0.312	D	c	-0.275	-0.112	1.000	0.747	0.437	0.062	0	4.02	0.458	2.871	0.479	0.952	0.539	1.000	0.715	0.829	0.346	9.679	0.390	.	.	.	0.5	.	97	chr2	187713713	chr2:187713713	G	T	.	PASS	AN=0;DP=97	GT	0/1
chr2	197786924	197786924	A	G	intronic	PGAP1	.	.	.	0.008785882	0.991209738	4.38E-06	DISEASE: Mental retardation, autosomal recessive 42 (MRT42) [MIM:615802]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:24784135}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24265	.	-0.666770504	15.86459071	57.58899	1.53274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	53	chr2	197786924	chr2:197786924	A	G	95	PASS	AN=2;DP=53	GT	0/1
chr2	218723107	218723107	G	C	intronic	TNS1	.	.	.	0.924939889	0.075060111	5.03E-11	.	0.49253	0.15564	1.585596299	95.81269167	8076.56687	19.41076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	197	chr2	218723107	chr2:218723107	G	C	140	PASS	AN=2;DP=197	GT	0/1
chr2	228109625	228109625	-	TG	ncRNA_intronic	LOC654841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	74	chr2	228109625	chr2:228109625	T	TTG	51	PASS	AN=2;DP=74	GT	0/1
chr2	233245026	233245026	G	A	exonic	ALPP	.	nonsynonymous SNV	ALPP:NM_001632:exon6:c.G788A:p.R263H	1.69E-06	0.862682097	0.137316218	.	0.11261	0.13673	1.35769336	94.43854683	1957.1571	8.14348	0.877	0.026	T	0.007	0.131	B	0.001	0.040	B	0.991	0.079	N	1	0.090	P	-1	0.012	N	-4.04	0.965	D	0.35	0.038	N	0.093	0.092	-0.828	0.535	T	0.002	0.006	T	.	.	.	0.356	0.128	6.224	0.762	0.110	0.008	0.032	N	c	-1.491	-1.418	0.004	0.106	0.497	0.185	0	-0.177	0.126	0.494	0.220	-0.025	0.128	0.000	0.063	0.021	0.135	7.139	0.246	Alkaline phosphatase-like, alpha/beta/alpha|Alkaline-phosphatase-like, core domain	ENSG00000244280.1|ENSG00000244280.1	Testis|Thyroid	0.5	.	294	chr2	233245026	chr2:233245026	G	A	.	PASS	AN=0;DP=294	GT	0/1
chr3	10367959	10367959	A	G	UTR3	ATP2B2	NM_001683:c.*2539T>C;NM_001330611:c.*2898T>C;NM_001001331:c.*2539T>C	.	.	0.999921506	7.85E-05	8.79E-13	.	0.69922	0.18045	-1.943881244	1.893135173	96.26442	2.12107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	84	chr3	10367959	chr3:10367959	A	G	74	PASS	AN=2;DP=84	GT	0/1
chr3	14208625	14208625	G	C	intronic	XPC	.	.	.	1.32E-10	0.769528282	0.230471718	DISEASE: Xeroderma pigmentosum complementation group C (XP-C) [MIM:278720]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. {ECO:0000269|PubMed:10766188, ECO:0000269|PubMed:8298653}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28185	0.48408	0.45192103	78.03727294	310.38459	3.74818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	31	chr3	14208625	chr3:14208625	G	C	107	PASS	AN=2;DP=31	GT	0/1
chr3	52858010	52858010	G	A	exonic;splicing	ITIH4;ITIH4-AS1	NR_046615:exon1:c.59+1G>A	synonymous SNV	ITIH4:NM_001166449:exon10:c.C1182T:p.N394N,ITIH4:NM_002218:exon10:c.C1182T:p.N394N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	chr3	52858010	chr3:52858010	G	A	.	PASS	AN=0;DP=93	GT	0/1
chr3	65438846	65438846	C	T	intronic	MAGI1	.	.	.	0.999615675	0.000384325	2.89E-15	.	0.27232	0.12487	-1.383523256	4.358339231	581.76428	4.88893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	37	chr3	65438846	chr3:65438846	C	T	40	PASS	AN=2;DP=37	GT	0/1
chr3	101576029	101576029	-	ACTTTTAGAAAGCTTTAATAACC	splicing	NFKBIZ	NM_001005474:exon11:c.1635+2->ACTTTTAGAAAGCTTTAATAACC;NM_031419:exon10:c.1935+2->ACTTTTAGAAAGCTTTAATAACC	.	.	0.999616951	0.000383048	1.02E-09	.	0.49089	0.09707	-0.622676946	17.30950696	64.66853	1.65031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	31	chr3	101576029	chr3:101576029	T	TACTTTTAGAAAGCTTTAATAACC	76	PASS	AN=2;DP=31	GT	0/1
chr3	131081092	131081092	G	A	ncRNA_exonic	NUDT16P1	.	.	.	.	.	.	.	0.10767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	400	chr3	131081092	chr3:131081092	G	A	117	PASS	AN=2;DP=400	GT	0/1
chr3	157822822	157822822	C	-	intronic	SHOX2	.	.	.	0.085211228	0.905107645	0.009681127	.	0.83131	0.12971	-0.405853867	26.23260203	17.09768	0.60161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	318	chr3	157822821	chr3:157822821	GC	G	156	PASS	AN=2;DP=318	GT	0/1
chr4	17493754	17493754	G	C	intronic	QDPR	.	.	.	0.065816427	0.919602835	0.014580737	DISEASE: Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]: Rare autosomal recessive disorder characterized by hyperphenylalaninemia and severe neurologic symptoms (malignant hyperphenylalaninemia) including axial hypotonia and truncal hypertonia, abnormal thermogenesis, and microcephaly. These signs are attributable to depletion of the neurotransmitters dopamine and serotonin, whose syntheses are controlled by tryptophan and tyrosine hydroxylases that use BH-4 as cofactor. Patients do not respond to phenylalanine-restricted diet. HPABH4C is lethal if untreated. {ECO:0000269|PubMed:10408783, ECO:0000269|PubMed:11153907, ECO:0000269|PubMed:2116088, ECO:0000269|PubMed:8326489, ECO:0000269|PubMed:9744478}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1631	0.40344	-0.383807564	27.41802312	13.56109	0.4928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	204	chr4	17493754	chr4:17493754	G	C	96	PASS	AN=2;DP=204	GT	0/1
chr4	159754866	159754866	T	-	intronic	FNIP2	.	.	.	0.997777002	0.002222998	6.15E-10	.	0.11511	0.08281	-0.10469683	45.64755839	731.02841	5.36823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	119	chr4	159754865	chr4:159754865	GT	G,GTT	53	PASS	AN=2;DP=119	GT	0/1
chr4	159754866	159754866	-	T	intronic	FNIP2	.	.	.	0.997777002	0.002222998	6.15E-10	.	0.11511	0.08281	-0.10469683	45.64755839	731.02841	5.36823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	119	chr4	159754865	chr4:159754865	GT	G,GTT	53	PASS	AN=2;DP=119	GT	0/1
chr5	6651976	6651976	G	C	exonic	SRD5A1	.	synonymous SNV	SRD5A1:NM_001047:exon2:c.G315C:p.L105L,SRD5A1:NM_001324323:exon3:c.G96C:p.L32L	1.82E-06	0.252700789	0.747297393	.	0.05869	.	-0.073340031	48.11866006	31.3139	0.98785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	51	chr5	6651976	chr5:6651976	G	C	66	PASS	AN=2;DP=51	GT	0/1
chr5	79351686	79351686	G	A	exonic	THBS4	.	nonsynonymous SNV	THBS4:NM_001306214:exon3:c.G98A:p.R33Q,THBS4:NM_003248:exon3:c.G371A:p.R124Q,THBS4:NM_001306212:exon4:c.G98A:p.R33Q,THBS4:NM_001306213:exon4:c.G98A:p.R33Q	1.74E-08	0.998069808	0.001930175	.	0.18964	0.34036	-0.23697515	36.32342534	1138.51791	6.43453	0.641	0.050	T	0.026	0.181	B	0.005	0.104	B	0.001	0.403	N	0.573	0.311	N	0.895	0.225	L	4.44	0.022	T	-0.53	0.164	N	0.097	0.112	-0.979	0.353	T	0.006	0.021	T	0.006	0.145	T	4.129	0.554	23.8	0.984	0.408	0.557	0.297	D	c	-0.201	-0.013	1.000	0.747	0.742	0.980	0	5.84	0.934	3.131	0.500	0.998	0.613	1.000	0.715	0.862	0.360	9.776	0.396	Concanavalin A-like lectin/glucanase domain|Laminin G domain	.	.	0.5	91	294	chr5	79351686	chr5:79351686	G	A	91	PASS	AN=2;DP=294	GT	0/1
chr5	139227250	139227250	T	-	UTR3	NRG2	NM_001184935:c.*252delA;NM_004883:c.*252delA;NM_013981:c.*252delA;NM_013982:c.*252delA;NM_013983:c.*252delA	.	.	0.995154288	0.004845611	1.01E-07	.	0.87096	0.14813	.	.	357.16396	4.00512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	102	chr5	139227249	chr5:139227249	CT	C,CTT	74	PASS	AN=2;DP=102	GT	0/1
chr5	139227250	139227250	-	T	UTR3	NRG2	NM_001184935:c.*251_*252insA;NM_004883:c.*251_*252insA;NM_013981:c.*251_*252insA;NM_013982:c.*251_*252insA;NM_013983:c.*251_*252insA	.	.	0.995154288	0.004845611	1.01E-07	.	0.87096	0.14813	.	.	357.16396	4.00512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	102	chr5	139227249	chr5:139227249	CT	C,CTT	74	PASS	AN=2;DP=102	GT	0/1
chr5	175792720	175792720	G	T	exonic	ARL10	.	nonsynonymous SNV	ARL10:NM_001317948:exon1:c.G154T:p.A52S,ARL10:NM_173664:exon1:c.G154T:p.A52S	4.90E-05	0.425964378	0.573986583	.	0.34084	.	-0.05129383	49.75819769	24.49093	0.80498	0.721	0.039	T	0.008	0.151	B	0.011	0.145	B	0.969	0.082	N	1	0.090	N	0.205	0.094	N	0.18	0.604	T	0.14	0.054	N	0.125	0.141	-1.017	0.246	T	0.096	0.361	T	0.739	0.979	D	-1.053	0.030	0.012	0.913	0.200	0.031	0.079	N	c	-1.241	-1.206	1.000	0.747	0.564	0.319	0	2.2	0.268	0.598	0.236	-0.044	0.124	0.000	0.063	0.526	0.275	8.926	0.346	.	.	.	0.5	76	87	chr5	175792720	chr5:175792720	G	T	76	PASS	AN=2;DP=87	GT	0/1
chr6	32489753	32489753	C	G	exonic	HLA-DRB5	.	nonsynonymous SNV	HLA-DRB5:NM_002125:exon2:c.G299C:p.R100T	0.003227266	0.824923015	0.171849719	.	0.04311	0.1359	4.551415577	99.75230007	16958.17858	27.72811	0.044	0.410	D	0.006	0.309	B	0.01	0.581	B	0.000	0.002	N	1	0.090	N	1.105	0.287	L	8.05	0.003	T	-1.46	0.358	N	0.219	0.269	-0.935	0.435	T	0.000	0.002	T	.	.	.	-2.779	0.002	0.001	0.804	0.128	0.009	0.034	N	c	-2.193	-2.414	1.000	0.747	0.660	0.490	0	-9.43	0.005	-15.955	0.000	-7.606	0.000	0.000	0.063	0.000	0.016	2.902	0.053	MHC class II, alpha/beta chain, N-terminal|MHC class II, beta chain, N-terminal|MHC classes I/II-like antigen recognition protein	.	.	0.5	54	81	chr6	32489753	chr6:32489753	C	G	54	PASS	AN=2;DP=81	GT	0/1
chr6	34059787	34059787	C	T	exonic	GRM4	.	synonymous SNV	GRM4:NM_001256809:exon2:c.G402A:p.T134T,GRM4:NM_001256812:exon2:c.G102A:p.T34T,GRM4:NM_000841:exon3:c.G609A:p.T203T,GRM4:NM_001256811:exon3:c.G609A:p.T203T,GRM4:NM_001256813:exon3:c.G210A:p.T70T	0.979350085	0.020649771	1.44E-07	.	0.27001	0.19777	-2.478673049	0.96131163	76.44854	1.83436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	chr6	34059787	chr6:34059787	C	T	.	PASS	AN=0;DP=112	GT	0/1
chr7	47979921	47979921	A	-	intronic	PKD1L1	.	.	.	1.72E-23	0.999996492	3.51E-06	.	0.07124	.	2.171086137	98.04788865	3392.60955	11.14655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	38	chr7	47979920	chr7:47979920	GA	G,GAA	45	PASS	AN=2;DP=38	GT	0/1
chr7	47979921	47979921	-	A	intronic	PKD1L1	.	.	.	1.72E-23	0.999996492	3.51E-06	.	0.07124	.	2.171086137	98.04788865	3392.60955	11.14655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	38	chr7	47979920	chr7:47979920	GA	G,GAA	45	PASS	AN=2;DP=38	GT	0/1
chr7	76610356	76610356	C	-	ncRNA_exonic	DTX2P1-UPK3BP1-PMS2P11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	867	chr7	76610355	chr7:76610355	AC	A	119	PASS	AN=2;DP=867	GT	0/1
chr7	87005287	87005287	-	T	intronic	CROT	.	.	.	6.75E-21	0.003162599	0.996837401	.	0.08801	0.20255	-0.374708069	28.15522529	169.89771	2.84516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	34	chr7	87005287	chr7:87005287	C	CT	84	PASS	AN=2;DP=34	GT	0/1
chr7	100608268	100608268	-	CTTAACCCCTTGAT	intronic	MUC3A	.	.	.	.	.	.	.	.	.	.	.	4720.00036	13.87692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	133	chr7	100608268	chr7:100608268	C	CCTTAACCCCTTGAT	142	PASS	AN=2;DP=133	GT	0/1
chr7	107052928	107052929	AC	-	intronic	COG5	.	.	.	1.14E-11	0.904490338	0.095509662	DISEASE: Congenital disorder of glycosylation 2I (CDG2I) [MIM:613612]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Congenital disorder of glycosylation type 2I is characterized by mild neurological impairments. {ECO:0000269|PubMed:19690088}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69254	0.10021	-0.016511957	52.31776362	860.42254	5.72159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	51	chr7	107052927	chr7:107052927	AAC	A	115	PASS	AN=2;DP=51	GT	0/1
chr7	151935853	151935853	T	C	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon15:c.A2591G:p.E864G	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.077	0.346	T	0.986	0.596	D	0.655	0.508	P	0.010	0.301	N	1.000	0.488	D	1.95	0.526	M	-2.06	0.860	D	-1.73	0.410	N	0.593	0.620	-0.013	0.820	T	0.585	0.851	D	.	.	.	4.196	0.562	23.9	0.998	0.907	0.978	0.770	D	c	0.478	0.540	1.000	0.747	0.651	0.465	0	5.53	0.825	7.411	0.791	1.061	0.807	1.000	0.715	1.000	0.888	15.955	0.796	.	.	.	0.5	146	120	chr7	151935853	chr7:151935853	T	C	146	PASS	AN=2;DP=120	GT	0/1
chr8	17501955	17501955	-	AGAT	UTR3	MTUS1	NM_001166393:c.*1479_*1480insATCT;NM_020749:c.*1479_*1480insATCT;NM_001330470:c.*1479_*1480insATCT;NM_001001931:c.*1479_*1480insATCT;NM_001001924:c.*1479_*1480insATCT;NM_001001925:c.*1479_*1480insATCT	.	.	1.14E-05	0.999473952	0.00051461	DISEASE: Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. {ECO:0000269|PubMed:16650523}. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.16371	0.10477	2.096551086	97.87096013	1447.42658	7.09602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	18	chr8	17501955	chr8:17501955	G	GAGAT	85	PASS	AN=2;DP=18	GT	1/0
chr8	142517131	142517131	G	-	intronic	MROH5	.	.	.	.	.	.	.	.	.	4.384391577	99.74050484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	100	chr8	142517130	chr8:142517130	TG	T	159	PASS	AN=2;DP=100	GT	1/0
chr9	44093256	44093256	A	G	intergenic	CNTNAP3P2;XLOC_007697	dist=169199;dist=88255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	302	chr9	44093256	chr9:44093256	A	G	90	PASS	AN=2;DP=302	GT	0/1
chr9	68433481	68433481	-	CTC	ncRNA_exonic	FRG1JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	121	chr9	68433481	chr9:68433481	T	TCTC	107	PASS	AN=2;DP=121	GT	0/1
chr9	69067893	69067897	AAAAG	-	ncRNA_exonic	FRG1HP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	102	chr9	69067892	chr9:69067892	AAAAAG	A	86	PASS	AN=2;DP=102	GT	0/1
chr10	6506209	6506209	-	A	intronic	PRKCQ	.	.	.	0.967595406	0.032404576	1.80E-08	.	0.6701	0.45889	-0.378346116	28.01368247	672.23761	5.1805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	42	chr10	6506209	chr10:6506209	G	GA	39	PASS	AN=2;DP=42	GT	0/1
chr10	11367781	11367781	T	-	ncRNA_intronic	CELF2-AS1	.	.	.	.	.	.	.	0.03536	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	39	chr10	11367780	chr10:11367780	CT	C	117	PASS	AN=2;DP=39	GT	0/1
chr10	43694491	43694491	G	-	intronic	RASGEF1A	.	.	.	0.910096302	0.089875281	2.84E-05	.	0.28193	0.10809	0.084621747	60.31493277	52.5675	1.43524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	344	chr10	43694490	chr10:43694490	CG	C	78	PASS	AN=2;DP=344	GT	0/1
chr10	46217869	46217869	C	G	intergenic	ZFAND4;WASHC2C	dist=49608;dist=4779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	107	chr10	46217869	chr10:46217869	C	G	122	PASS	AN=2;DP=107	GT	0/1
chr10	116196144	116196144	A	-	intronic	ABLIM1	.	.	.	0.951991965	0.048008025	9.69E-09	.	0.24692	0.11524	-0.24061166	36.28214201	426.69086	4.31466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	20	chr10	116196143	chr10:116196143	GA	G	64	PASS	AN=2;DP=20	GT	0/1
chr10	118927199	118927276	GGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	-	ncRNA_exonic	MIR3663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	584	chr10	118927198	chr10:118927198	TGGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	T	90	PASS	AN=2;DP=584	GT	0/1
chr11	61539013	61539013	C	-	exonic	MYRF	.	frameshift deletion	MYRF:NM_001127392:exon6:c.782delC:p.S264Afs*7,MYRF:NM_013279:exon6:c.755delC:p.S255Afs*7	0.999847803	0.000152197	4.41E-12	.	0.22352	0.1057	-1.082044518	7.242274121	229.21291	3.27206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	500	chr11	61539012	chr11:61539012	TC	T	75	PASS	AN=2;DP=500	GT	0/1
chr11	71507263	71507263	A	G	ncRNA_intronic	ALG1L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	631	chr11	71507263	chr11:71507263	A	G	148	PASS	AN=2;DP=631	GT	0/1
chr11	106408032	106408037	CAAATG	-	intergenic	LOC101928535;GUCY1A2	dist=272400;dist=136701	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	30	chr11	106408031	chr11:106408031	TCAAATG	T	85	PASS	AN=2;DP=30	GT	0/1
chr11	123909691	123909691	T	G	exonic	OR10G7	.	synonymous SNV	OR10G7:NM_001004463:exon1:c.A18C:p.L6L	0.007122109	0.531402926	0.461474965	.	0.06744	0.08917	1.774838537	96.82118424	459.74042	4.44864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	147	chr11	123909691	chr11:123909691	T	G	135	PASS	AN=2;DP=147	GT	0/1
chr12	8074168	8074168	A	G	exonic	SLC2A3	.	synonymous SNV	SLC2A3:NM_006931:exon10:c.T1332C:p.A444A	0.519822946	0.47941858	0.000758474	.	0.35764	0.14971	0.619191319	83.36282142	55.14143	1.4881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	50	chr12	8074168	chr12:8074168	A	G	61	PASS	AN=2;DP=50	GT	0/1
chr12	86229896	86229896	G	C	intronic	RASSF9	.	.	.	7.70E-05	0.755070432	0.244852527	.	0.22794	0.10688	0.376678994	75.50719509	331.1863	3.8715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	57	chr12	86229896	chr12:86229896	G	C	78	PASS	AN=2;DP=57	GT	0/1
chr12	86229898	86229898	G	C	intronic	RASSF9	.	.	.	7.70E-05	0.755070432	0.244852527	.	0.22794	0.10688	0.376678994	75.50719509	331.1863	3.8715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	56	chr12	86229898	chr12:86229898	G	C	72	PASS	AN=2;DP=56	GT	0/1
chr12	108913293	108913293	A	-	UTR3	FICD	NM_007076:c.*41delA	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	127	chr12	108913292	chr12:108913292	GA	G	77	PASS	AN=2;DP=127	GT	0/1
chr13	19393160	19393160	G	A	ncRNA_intronic	ANKRD20A9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	58	chr13	19393160	chr13:19393160	G	A	65	PASS	AN=2;DP=58	GT	0/1
chr13	25161438	25161438	T	A	ncRNA_exonic	TPTE2P6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	112	chr13	25161438	chr13:25161438	T	A	120	PASS	AN=2;DP=112	GT	0/1
chr13	52333956	52333968	TTAACCCAAATCA	-	UTR3	WDFY2	NM_052950:c.*51_*63delTTAACCCAAATCA	.	.	0.003595002	0.987074972	0.009330027	.	0.16955	0.11257	-0.047654689	50.22410946	302.50677	3.70419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	34	chr13	52333955	chr13:52333955	TTTAACCCAAATCA	T	95	PASS	AN=2;DP=34	GT	0/1
chr13	113473599	113473600	AT	-	intronic	ATP11A	.	.	.	0.967333743	0.032666257	3.07E-11	.	0.22056	0.10642	-1.605857744	3.007784855	269.18999	3.51905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	107	chr13	113473598	chr13:113473598	CAT	C	145	PASS	AN=2;DP=107	GT	0/1
chr14	19378020	19378020	C	A	exonic	OR11H12	.	nonsynonymous SNV	OR11H12:NM_001013354:exon1:c.C427A:p.R143S	0.79839868	0.196005182	0.005596138	.	.	.	.	.	4405.8371	13.26123	0.075	0.344	T	0.162	0.268	B	0.039	0.223	B	0.819	0.092	N	.	.	.	1.19	0.302	L	5.03	0.013	T	-3.74	0.710	D	0.161	0.193	-0.951	0.408	T	0.004	0.014	T	.	.	.	0.707	0.161	8.876	0.755	0.107	0.005	0.022	N	c	-1.241	-1.393	0.000	0.012	0.487	0.133	0	-1.17	0.091	-5.359	0.002	0.200	0.252	0.000	0.063	0.008	0.104	6.168	0.195	GPCR, rhodopsin-like, 7TM	.	.	0.5	124	341	chr14	19378020	chr14:19378020	C	A	124	PASS	AN=2;DP=341	GT	0/1
chr14	73442401	73442403	TTG	-	exonic	ZFYVE1	.	nonframeshift deletion	ZFYVE1:NM_001281735:exon6:c.417_419del:p.N140del,ZFYVE1:NM_178441:exon6:c.417_419del:p.N140del,ZFYVE1:NM_001281734:exon9:c.1620_1622del:p.N541del,ZFYVE1:NM_021260:exon9:c.1662_1664del:p.N555del	0.953726203	0.04627273	1.07E-06	.	0.28604	0.1203	-1.195919584	5.832743572	270.27144	3.52655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	63	chr14	73442400	chr14:73442400	ATTG	A	106	PASS	AN=2;DP=63	GT	0/1
chr14	106137412	106137412	-	A	ncRNA_intronic	ELK2AP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.45	126	chr14	106137412	chr14:106137412	G	GA	14.45	PASS	AN=0;DP=126	GT	0/1
chr14	106780803	106780803	C	G	intergenic	LINC00226;LINC00221	dist=35837;dist=157642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	185	chr14	106780803	chr14:106780803	C	G	121	PASS	AN=2;DP=185	GT	0/1
chr15	25299375	25299375	-	A	ncRNA_exonic	SNORD116-2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	111	chr15	25299375	chr15:25299375	C	CA	50	PASS	AN=2;DP=111	GT	0/1
chr15	28419779	28419779	A	G	intronic	HERC2	.	.	.	1	3.99E-17	4.70E-51	DISEASE: Mental retardation, autosomal recessive 38 (MRT38) [MIM:615516]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT38 is characterized by global developmental delay affecting motor, speech, adaptive, and social development. Patients manifest autistic features, aggression, self-injury, impulsivity, and distractibility. {ECO:0000269|PubMed:23065719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24532	0.21556	-5.985628431	0.047180939	2166.06955	8.56756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	128	chr15	28419779	chr15:28419779	A	G	93	PASS	AN=2;DP=128	GT	0/1
chr15	30771339	30771339	A	G	ncRNA_exonic	LOC100288203	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	116	chr15	30771339	chr15:30771339	A	G	89	PASS	AN=2;DP=116	GT	0/1
chr15	66786707	66786709	GAG	-	UTR3	SNAPC5	NM_001329615:c.*67_*65delCTC;NM_001329614:c.*67_*65delCTC;NM_001329613:c.*67_*65delCTC	.	.	1.40E-05	0.125603911	0.874382068	.	0.08216	0.11262	-0.09720619	46.20193442	24.24987	0.79777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	38	chr15	66786706	chr15:66786706	TGAG	T	105	PASS	AN=2;DP=38	GT	0/1
chr15	74368297	74368297	C	G	exonic	GOLGA6A	.	nonsynonymous SNV	GOLGA6A:NM_001038640:exon8:c.G594C:p.Q198H	0.224411354	0.739591664	0.035996982	.	.	0.07726	.	.	525.23752	4.67589	0.099	0.306	T	0.966	0.542	D	0.891	0.614	P	.	.	.	1	0.090	N	2.4	0.697	M	1.85	0.245	T	-2.28	0.508	N	0.036	0.016	-1.040	0.172	T	0.079	0.313	T	.	.	.	1.002	0.190	10.67	0.970	0.314	0.001	0.007	N	c	-0.614	-0.905	0.000	0.052	0.554	0.246	0	-1.05	0.095	-1.640	0.021	-0.440	0.057	0.000	0.063	0.000	0.016	5.104	0.140	.	.	.	0.5	145	145	chr15	74368297	chr15:74368297	C	G	145	PASS	AN=2;DP=145	GT	0/1
chr15	77310786	77310786	T	-	intronic	PSTPIP1	.	.	.	0.00072615	0.980795876	0.018477974	DISEASE: PAPA syndrome (PAPAS) [MIM:604416]: Characterized by autosomal dominant inheritance of early-onset, primarily affecting skin and joint tissues. Recurring inflammatory episodes lead to accumulation of sterile, pyogenic, neutrophil-rich material within the affected joints, ultimately resulting in significant destruction. {ECO:0000269|PubMed:11971877, ECO:0000269|PubMed:22161697}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18907	0.17191	0.312359769	72.71172446	220.82961	3.2135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	239	chr15	77310785	chr15:77310785	CT	C,CTT	66	PASS	AN=2;DP=239	GT	0/1
chr15	77310786	77310786	-	T	intronic	PSTPIP1	.	.	.	0.00072615	0.980795876	0.018477974	DISEASE: PAPA syndrome (PAPAS) [MIM:604416]: Characterized by autosomal dominant inheritance of early-onset, primarily affecting skin and joint tissues. Recurring inflammatory episodes lead to accumulation of sterile, pyogenic, neutrophil-rich material within the affected joints, ultimately resulting in significant destruction. {ECO:0000269|PubMed:11971877, ECO:0000269|PubMed:22161697}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18907	0.17191	0.312359769	72.71172446	220.82961	3.2135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	239	chr15	77310785	chr15:77310785	CT	C,CTT	66	PASS	AN=2;DP=239	GT	0/1
chr15	78207569	78207569	G	A	ncRNA_exonic	LOC645752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	139	chr15	78207569	chr15:78207569	G	A	.	PASS	AN=0;DP=139	GT	0/1
chr16	3131940	3131940	-	GG	intergenic	IL32;ZSCAN10	dist=12120;dist=6951	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	76	chr16	3131940	chr16:3131940	C	CGG	90	PASS	AN=2;DP=76	GT	0/1
chr16	20448536	20448536	A	G	intronic	ACSM5	.	.	.	5.09E-08	0.838533958	0.161465991	.	0.05514	0.09249	3.184574415	99.32767162	7462.84206	18.58355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	96	chr16	20448536	chr16:20448536	A	G	75	PASS	AN=2;DP=96	GT	0/1
chr16	28354353	28354353	T	G	exonic	NPIPB6	.	nonsynonymous SNV	NPIPB6:NM_001282524:exon7:c.A853C:p.T285P	0.636136512	0.335207165	0.028656323	.	.	.	.	.	364.15712	4.03989	1.0	0.010	T	0.001	0.067	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.05	0.002	N	1.83	0.248	T	4.72	0.000	N	0.045	0.025	-1.037	0.182	T	0.011	0.041	T	.	.	.	-3.438	0.000	0.001	0.069	0.000	0.000	0.002	N	c	-2.800	-2.809	0.142	0.173	0.638	0.428	0	.	.	-4.246	0.003	-4.857	0.000	0.001	0.137	0.000	0.016	.	.	.	.	.	0.5	87	39	chr16	28354353	chr16:28354353	T	G	87	PASS	AN=2;DP=39	GT	0/1
chr16	29889679	29889679	A	G	exonic	SEZ6L2	.	synonymous SNV	SEZ6L2:NM_001114100:exon8:c.T1299C:p.Y433Y,SEZ6L2:NM_001243333:exon9:c.T1509C:p.Y503Y,SEZ6L2:NM_001114099:exon10:c.T1431C:p.Y477Y,SEZ6L2:NM_001243332:exon10:c.T1641C:p.Y547Y,SEZ6L2:NM_012410:exon10:c.T1431C:p.Y477Y,SEZ6L2:NM_201575:exon10:c.T1641C:p.Y547Y	0.13015316	0.869807213	3.96E-05	.	0.53499	0.10324	-1.124330456	6.575843359	637.27687	5.07921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	294	chr16	29889679	chr16:29889679	A	G	150	PASS	AN=2;DP=294	GT	0/1
chr16	57509698	57509699	CT	-	intronic	DOK4	.	.	.	0.19760291	0.792064709	0.010332382	.	0.55569	0.13588	-0.66859065	15.76433121	109.57389	2.27428	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	257	chr16	57509697	chr16:57509697	CCT	C	103	PASS	AN=2;DP=257	GT	0/1
chr16	84035871	84035871	G	T	intronic	NECAB2	.	.	.	.	.	.	.	0.13866	0.11297	-0.126743121	44.0905874	2833.50108	10.05093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	126	chr16	84035871	chr16:84035871	G	T	.	PASS	AN=0;DP=126	GT	0/1
chr17	4750525	4750525	-	TTCA	intronic	MINK1	.	.	.	0.999984022	1.60E-05	7.45E-16	.	0.46968	0.13857	-1.456898556	3.862939372	2119.37505	8.47592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	39	chr17	4750525	chr17:4750525	G	GTTCA	87	PASS	AN=2;DP=39	GT	0/1
chr17	15522759	15522759	A	T	exonic	CDRT1	.	nonsynonymous SNV	CDRT1:NM_001282540:exon1:c.T68A:p.I23N,CDRT1:NM_006382:exon1:c.T68A:p.I23N	.	.	.	.	.	.	0.846940207	88.47605567	5108.29652	14.68503	0.024	0.481	D	0.553	0.363	P	0.146	0.323	B	.	.	.	1.000	0.186	N	0.69	0.170	N	1.84	0.247	T	-2.82	0.620	D	0.216	0.265	-0.981	0.349	T	0.000	0.002	T	.	.	.	1.532	0.246	13.48	0.899	0.186	0.124	0.171	N	c	-0.830	-0.838	0.286	0.190	0.526	0.212	0	3.92	0.444	1.613	0.363	0.223	0.255	0.023	0.197	0.002	0.062	10.567	0.442	.	.	.	0.5	.	62	chr17	15522759	chr17:15522759	A	T	.	PASS	AN=0;DP=62	GT	0/1
chr17	20769722	20769722	A	T	intronic	CCDC144NL	.	.	.	8.14E-06	0.171830686	0.828161171	.	.	.	1.26585432	93.59518754	271.43253	3.53005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	141	chr17	20769722	chr17:20769722	A	T	.	PASS	AN=0;DP=141	GT	0/1
chr17	21216758	21216758	-	CTTC	intronic	MAP2K3	.	.	.	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	154	140	chr17	21216758	chr17:21216758	G	GCTTC	154	PASS	AN=2;DP=140	GT	0/1
chr17	25783897	25783897	G	A	intergenic	TBC1D3P5;KSR1	dist=25248;dist=15139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	395	chr17	25783897	chr17:25783897	G	A	128	PASS	AN=2;DP=395	GT	0/1
chr17	39203522	39203534	TGGTGTCTGAGGC	-	UTR5	KRTAP2-1	NM_001123387:c.-3_-15delGCCTCAGACACCA	.	.	.	.	.	.	0.24626	.	.	.	6079.05555	16.29512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	231	chr17	39203521	chr17:39203521	GTGGTGTCTGAGGC	G	122	PASS	AN=2;DP=231	GT	0/1
chr17	43626397	43626397	G	C	intergenic	LRRC37A4P;MAPK8IP1P2	dist=28508;dist=51072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	273	chr17	43626397	chr17:43626397	G	C	103	PASS	AN=2;DP=273	GT	0/1
chr17	45364391	45364395	TTTGT	-	intronic	ITGB3	.	.	.	0.141699545	0.858266504	3.40E-05	DISEASE: Glanzmann thrombasthenia (GT) [MIM:273800]: A common inherited disease of platelet aggregation. It is characterized by mucocutaneous bleeding of mild-to-moderate severity. GT has been classified clinically into types I and II. In type I, platelets show absence of the glycoprotein IIb-IIIa complexes at their surface and lack fibrinogen and clot retraction capability. In type II, the platelets express the GPIIb-IIIa complex at reduced levels, have detectable amounts of fibrinogen, and have low or moderate clot retraction capability. {ECO:0000269|PubMed:10233432, ECO:0000269|PubMed:11588040, ECO:0000269|PubMed:11897046, ECO:0000269|PubMed:12083483, ECO:0000269|PubMed:12353082, ECO:0000269|PubMed:1371279, ECO:0000269|PubMed:1438206, ECO:0000269|PubMed:15583747, ECO:0000269|PubMed:15634267, ECO:0000269|PubMed:15748237, ECO:0000269|PubMed:1602006, ECO:0000269|PubMed:20020534, ECO:0000269|PubMed:2392682, ECO:0000269|PubMed:8781422, ECO:0000269|PubMed:9215749, ECO:0000269|PubMed:9376589, ECO:0000269|PubMed:9684783, ECO:0000269|PubMed:9790984}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bleeding disorder, platelet-type 16 (BDPLT16) [MIM:187800]: An autosomal dominant form of congenital macrothrombocytopenia associated with platelet anisocytosis. It is a disorder of platelet production. Affected individuals may have no or only mildly increased bleeding tendency. In vitro studies show mild platelet functional abnormalities. {ECO:0000269|PubMed:18065693}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54409	0.86055	-1.017713296	8.103326256	169.39233	2.84003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	32	chr17	45364390	chr17:45364390	ATTTGT	A	78	PASS	AN=2;DP=32	GT	0/1
chr17	61939715	61939715	C	A	ncRNA_exonic	TCAM1P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	104	chr17	61939715	chr17:61939715	C	A	72	PASS	AN=2;DP=104	GT	0/1
chr17	62007074	62007074	G	A	intronic	CD79B	.	.	.	0.950002657	0.049842119	0.000155224	DISEASE: Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:17675462}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24113	0.3219	-0.449946534	24.00330267	9.1864	0.3355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	121	chr17	62007074	chr17:62007074	G	A	.	PASS	AN=0;DP=121	GT	0/1
chr18	14837168	14837168	-	T	intronic	ANKRD30B	.	.	.	1.49E-09	0.94288369	0.057116308	.	.	.	1.06196211	91.507431	2417.32649	9.13836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	26	chr18	14837168	chr18:14837168	G	GT	40	PASS	AN=2;DP=26	GT	0/1
chr18	31323178	31323178	G	A	exonic	ASXL3	.	synonymous SNV	ASXL3:NM_030632:exon12:c.G3366A:p.Q1122Q	0.999977048	2.30E-05	8.90E-15	.	0.10816	.	-0.66524926	15.87048832	636.60276	5.07564	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	chr18	31323178	chr18:31323178	G	A	.	PASS	AN=0;DP=41	GT	0/1
chr18	34340634	34340634	G	A	exonic	FHOD3	.	nonsynonymous SNV	FHOD3:NM_001281739:exon22:c.G3913A:p.E1305K,FHOD3:NM_025135:exon23:c.G3964A:p.E1322K,FHOD3:NM_001281740:exon27:c.G4513A:p.E1505K	0.997517123	0.002482877	1.35E-12	.	0.22803	0.10389	-0.514518236	21.21962727	7901.72753	19.20257	0.098	0.308	T	0.592	0.372	P	0.254	0.374	B	0.000	0.843	D	1.000	0.588	D	1.895	0.505	L	1.44	0.369	T	-2.44	0.534	N	0.439	0.568	-1.102	0.039	T	0.071	0.288	T	0.018	0.396	T	3.289	0.454	22.8	0.998	0.874	0.995	0.962	D	c	0.117	0.227	1.000	0.747	0.758	0.990	0	5.16	0.704	9.443	0.967	1.048	0.713	1.000	0.715	0.324	0.241	15.386	0.743	Formin, FH2 domain	.	.	0.5	.	248	chr18	34340634	chr18:34340634	G	A	.	PASS	AN=0;DP=248	GT	0/1
chr19	9931194	9931194	A	-	intergenic	FBXL12;UBL5	dist=1415;dist=7362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	389	chr19	9931193	chr19:9931193	CA	C	109	PASS	AN=2;DP=389	GT	0/1
chr19	18887993	18887993	C	-	exonic	CRTC1	.	frameshift deletion	CRTC1:NM_015321:exon14:c.1706delC:p.S572Afs*5,CRTC1:NM_001098482:exon15:c.1754delC:p.S588Afs*5	0.980548236	0.01945115	6.14E-07	DISEASE: Note=A chromosomal aberration involving CRTC1 is found in mucoepidermoid carcinomas, benign Warthin tumors and clear cell hidradenomas. Translocation t(11;19)(q21;p13) with MAML2. The fusion protein consists of the N-terminus of CRTC1 joined to the C-terminus of MAML2. The reciprocal fusion protein consisting of the N-terminus of MAML2 joined to the C-terminus of CRTC1 has been detected in a small number of mucoepidermoid carcinomas.; 	0.23783	0.22982	-0.400392389	26.85185185	1186.85367	6.53335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	682	chr19	18887992	chr19:18887992	TC	T	103	PASS	AN=2;DP=682	GT	0/1
chr19	22940859	22940859	T	C	exonic	ZNF99	.	nonsynonymous SNV	ZNF99:NM_001080409:exon4:c.A1852G:p.K618E	3.04E-09	0.162337151	0.837662846	.	.	.	.	.	1840.35634	7.91225	1.0	0.010	T	0.006	0.126	B	0.013	0.154	B	.	.	.	1.000	0.206	N	-0.515	0.026	N	2.66	0.126	T	2.7	0.002	N	0.196	0.269	-0.943	0.422	T	0.009	0.032	T	0.001	0.008	T	-1.031	0.031	0.014	0.791	0.122	0.001	0.007	N	c	-1.539	-1.541	0.000	0.038	0.487	0.133	0	-0.667	0.108	-0.093	0.110	-1.414	0.012	0.000	0.063	0.000	0.016	6.213	0.197	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	65	41	chr19	22940859	chr19:22940859	T	C	65	PASS	AN=2;DP=41	GT	0/1
chr19	50463670	50463670	T	G	exonic	SIGLEC11	.	nonsynonymous SNV	SIGLEC11:NM_001135163:exon3:c.A469C:p.K157Q,SIGLEC11:NM_052884:exon3:c.A469C:p.K157Q	2.64E-08	0.478412852	0.521587121	.	0.07542	0.08273	0.846940207	88.47605567	1686.30736	7.57044	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.069	0.216	N	1	0.090	P	-3.23	0.000	N	4.04	0.032	T	2.48	0.002	N	0.021	0.005	-0.964	0.385	T	0.000	0.000	T	.	.	.	-1.721	0.012	0.002	0.118	0.002	0.000	0.002	N	c	-1.667	-1.590	0.001	0.075	0.487	0.133	0	-0.577	0.111	-0.136	0.103	-0.590	0.045	0.000	0.063	0.001	0.043	1.928	0.031	Immunoglobulin-like domain|Immunoglobulin-like fold	ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161643.8|ENSG00000105053.6|ENSG00000105053.6|ENSG00000221125.1|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161640.11	Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adrenal_Gland|Artery_Aorta|Artery_Tibial|Breast_Mammary_Tissue|Colon_Transverse|Esophagus_Mucosa|Lung|Lung|Skin_Sun_Exposed_Lower_leg|Spleen|Testis|Testis|Testis|Testis|Thyroid|Thyroid|Whole_Blood	0.5	181	494	chr19	50463670	chr19:50463670	T	G	181	PASS	AN=2;DP=494	GT	0/1
chr19	51274851	51274851	A	C	exonic	GPR32	.	nonsynonymous SNV	GPR32:NM_001506:exon1:c.A994C:p.T332P	7.91E-05	0.315038766	0.68488214	.	0.0893	.	0.108486928	61.90728946	99.68741	2.16289	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-1.72	0.003	N	1.24	0.367	T	3.88	0.001	N	0.074	0.064	-0.995	0.312	T	0.030	0.131	T	.	.	.	-1.311	0.022	0.004	0.827	0.139	0.001	0.005	N	c	-1.513	-1.493	0.002	0.089	0.497	0.185	0	-0.781	0.104	0.074	0.144	-0.869	0.028	0.000	0.063	0.757	0.323	3.651	0.077	.	.	.	0.5	102	177	chr19	51274851	chr19:51274851	A	C	102	PASS	AN=2;DP=177	GT	0/1
chr19	53805222	53805222	T	G	intergenic	BIRC8;ZNF845	dist=10347;dist=31750	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	117	chr19	53805222	chr19:53805222	T	G	146	PASS	AN=2;DP=117	GT	0/1
chr20	29624020	29624020	-	T	ncRNA_intronic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	96	chr20	29624020	chr20:29624020	G	GT	80	PASS	AN=2;DP=96	GT	0/1
chr20	57766219	57766219	-	C	exonic	ZNF831	.	frameshift insertion	ZNF831:NM_178457:exon1:c.146dupC:p.T52Hfs*46	7.65E-09	0.970919494	0.029080499	.	0.07141	.	1.328244615	94.10828025	431.43682	4.3351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	476	chr20	57766219	chr20:57766219	G	GC	75	PASS	AN=2;DP=476	GT	0/1
chr21	10909694	10909698	GCGAA	-	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	187	chr21	10909693	chr21:10909693	TGCGAA	T	94	PASS	AN=2;DP=187	GT	0/1
chr22	23735649	23735649	C	A	ncRNA_intronic	ZDHHC8P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	93	chr22	23735649	chr22:23735649	C	A	129	PASS	AN=2;DP=93	GT	0/1
chr22	38523469	38523469	C	A	intronic	PLA2G6	.	.	.	2.66E-08	0.901102432	0.098897542	DISEASE: Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]: A neurodegenerative disease characterized by pathologic axonal swelling and spheroid bodies in the central nervous system. Onset is within the first 2 years of life with death by age 10 years. {ECO:0000269|PubMed:16783378, ECO:0000269|PubMed:17033970, ECO:0000269|PubMed:23749988}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkinson disease 14 (PARK14) [MIM:612953]: An adult- onset progressive neurodegenerative disorder characterized by parkinsonism, dystonia, severe cognitive decline, cerebral and cerebellar atrophy and absent iron in the basal ganglia on magnetic resonance imaging. {ECO:0000269|PubMed:18570303}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16881	0.17642	-1.591018721	3.084453881	148.63297	2.65978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	161	chr22	38523469	chr22:38523469	C	A	.	PASS	AN=0;DP=161	GT	0/1
chr22	43274977	43274977	C	T	intronic	PACSIN2	.	.	.	0.270395757	0.729383646	0.000220597	.	0.24823	0.20703	0.044168103	57.40740741	250.49463	3.41008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	143	chr22	43274977	chr22:43274977	C	T	145	PASS	AN=2;DP=143	GT	0/1
